183 related articles for article (PubMed ID: 22511934)
1. CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposes against a murine melanoma.
Jellbauer S; Panthel K; Hetrodt JH; Rüssmann H
PLoS One; 2012; 7(4):e34214. PubMed ID: 22511934
[TBL] [Abstract][Full Text] [Related]
2. Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer.
Roider E; Jellbauer S; Köhn B; Berchtold C; Partilla M; Busch DH; Rüssmann H; Panthel K
Cancer Immunol Immunother; 2011 Mar; 60(3):371-80. PubMed ID: 21132428
[TBL] [Abstract][Full Text] [Related]
3. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
4. Anti-metastatic effects of DNA vaccine encoding single-chain trimer composed of MHC I and vascular endothelial growth factor receptor 2 peptide.
Chen R; Wang S; Yao Y; Zhou Y; Zhang C; Fang J; Zhang D; Zhang L; Pan J
Oncol Rep; 2015 May; 33(5):2269-76. PubMed ID: 25739076
[TBL] [Abstract][Full Text] [Related]
5. Identification of H-2Db-specific CD8+ T-cell epitopes from mouse VEGFR2 that can inhibit angiogenesis and tumor growth.
Dong Y; Qian J; Ibrahim R; Berzofsky JA; Khleif SN
J Immunother; 2006; 29(1):32-40. PubMed ID: 16365598
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
[TBL] [Abstract][Full Text] [Related]
7. Superior protective immunity against murine listeriosis by combined vaccination with CpG DNA and recombinant Salmonella enterica serovar typhimurium.
Berchtold C; Panthel K; Jellbauer S; Köhn B; Roider E; Partilla M; Heesemann J; Endres S; Bourquin C; Rüssmann H
Infect Immun; 2009 Dec; 77(12):5501-8. PubMed ID: 19797070
[TBL] [Abstract][Full Text] [Related]
8. [Specific anti-glioma angiogenesis immune response induced by attenuated Salmonella typhimurium vaccine expressing vascular endothelial growth factor receptor-2].
Feng KK; Zhao HY; Qiu H; Chen J
Ai Zheng; 2005 May; 24(5):548-53. PubMed ID: 15890095
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery by attenuated Salmonella typhimurium: comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination.
Weth R; Christ O; Stevanovic S; Zöller M
Cancer Gene Ther; 2001 Aug; 8(8):599-611. PubMed ID: 11571538
[TBL] [Abstract][Full Text] [Related]
10. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
Wang XY; Kazim L; Repasky EA; Subjeck JR
Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
[TBL] [Abstract][Full Text] [Related]
11. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
Mochimaru H; Nagai N; Hasegawa G; Kudo-Saito C; Yaguchi T; Usui Y; Kurihara T; Koto T; Satofuka S; Shinoda H; Ozawa Y; Tsubota K; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4795-801. PubMed ID: 17898306
[TBL] [Abstract][Full Text] [Related]
12. An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.
Seavey MM; Maciag PC; Al-Rawi N; Sewell D; Paterson Y
J Immunol; 2009 May; 182(9):5537-46. PubMed ID: 19380802
[TBL] [Abstract][Full Text] [Related]
13. Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis.
Sevil Domènech VE; Panthel K; Meinel KM; Winter SE; Rüssmann H
Microbes Infect; 2007 Oct; 9(12-13):1447-53. PubMed ID: 17913544
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
Pan J; Heiser A; Marget M; Steinmann J; Kabelitz D
Gene Ther; 2005 May; 12(9):742-50. PubMed ID: 15729371
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein.
Zhang M; Ishii K; Hisaeda H; Murata S; Chiba T; Tanaka K; Li Y; Obata C; Furue M; Himeno K
Immunology; 2004 Aug; 112(4):567-74. PubMed ID: 15270727
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.
Zhai Y; Yang JC; Kawakami Y; Spiess P; Wadsworth SC; Cardoza LM; Couture LA; Smith AE; Rosenberg SA
J Immunol; 1996 Jan; 156(2):700-10. PubMed ID: 8543823
[TBL] [Abstract][Full Text] [Related]
17. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth.
Niethammer AG; Xiang R; Becker JC; Wodrich H; Pertl U; Karsten G; Eliceiri BP; Reisfeld RA
Nat Med; 2002 Dec; 8(12):1369-75. PubMed ID: 12415261
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic anti-tumor immunity against a murine fibrosarcoma triggered by the Salmonella type III secretion system.
Panthel K; Meinel KM; Sevil Domènech VE; Geginat G; Linkemann K; Busch DH; Rüssmann H
Microbes Infect; 2006 Aug; 8(9-10):2539-46. PubMed ID: 16919987
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.
Kim B; Suvas S; Sarangi PP; Lee S; Reisfeld RA; Rouse BT
J Immunol; 2006 Sep; 177(6):4122-31. PubMed ID: 16951377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
